Embryonic stem cells are seen by many researchers as having great potential becausetheycan in theory be coaxed to create any kind of cell type in the body.
Not only canthey spend inordinately on shaky bets, but they may lock companies into wrong approaches because high upfront costs create reluctance to invest further in adjusting losing propositions.